Clinical Trial Update: Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia [NA]

View source ↗

Summary

A completed clinical trial investigated the effects of simvastatin and ezetimibe on cardiovascular risk markers in patients with dyslipidemia; results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | Conditions: Dyslipidemia | NA | Status: COMPLETED | Results posted: 2015-05-21